Applied DNA Sciences
Financial ratios & Valuation

Forward Multiples (2025 – 2025)

2025
Price/Earnings ratio
-3.76
Price/Sales ratio
3.96
Earnings per Share (EPS)
$-0.95

Historical Multiples (2015 – 2024)

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-8.16-5.93-5.88-3.55-0.95-2.37-2.32-1.20-1.59-0.35-1.82-2.37
Price/Sales ratio
10.7617.2615.9310.651.5215.684.120.551.180.750.7115.68
Price/Book Value ratio
7.716.9711.0355.12-9.795.293.350.783.190.281.49-9.79
Price/Cash Flow ratio
-13.92-7.30-10.12-6.01-1.20-2.71-2.78-1.12-2.54-0.18-1.78-2.71
Price/Free Cash Flow ratio
-12.75-6.76-9.92-5.79-1.18-2.48-2.33-1.07-2.51-0.18-1.70-2.48
Price/Earnings Growth ratio
0.230.321.130.190.020.030.080.020.080.00-0.030.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A1.08%N/A9.04%N/AN/A
Profitability Indicator Ratios
Gross Profit Margin
95.73%82.16%77.32%69.08%83.71%62.67%54.59%27.81%41.39%29.63%32.81%62.67%
Operating Profit Margin
-87.18%-291.41%-269.82%-298.36%-169.31%-648.97%-136.15%-76.88%-81.94%-408.71%-54.78%-169.31%
Pretax Profit Margin
-131.88%-290.84%-270.57%-299.56%-159.90%-674.54%-158.16%-45.51%-74.98%-206.57%-38.37%-159.90%
Net Profit Margin
-131.88%-290.84%-270.57%-299.56%-160.18%-660.88%-177.55%-46.11%-74.41%-210.57%-38.93%-160.18%
Effective Tax Rate
-67.35%0.19%-2.25%-0.39%-0.17%2.02%-12.26%-1.30%N/A-1.93%-1.44%2.02%
Return on Assets
-76.38%-78.22%-157.66%-207.55%-242.16%-112.55%-111.18%-37.62%-72.86%-56.49%-36.95%-242.16%
Return On Equity
-94.54%-117.46%-187.45%-1549.75%1025.89%-223.23%-144.22%-64.88%-200.90%-80.57%-82.17%-223.23%
Return on Capital Employed
-60.94%-106.26%-186.93%-414.18%-691.89%-177.16%-110.29%-77.26%-101.36%-134.97%-62.21%-691.89%
Liquidity Ratios
Current Ratio
4.322.774.811.410.952.12N/AN/AN/AN/A5.500.95
Quick Ratio
4.322.704.561.330.892.013.034.622.743.175.080.89
Cash ratio
2.741.092.280.580.241.822.003.632.512.683.860.24
Days of Sales Outstanding
159.21555.80198.81138.9456.8836.72113.3661.626.9738.5076.7956.88
Days of Inventory outstanding
0.00145.57110.6166.9559.31251.82121.9716.7615.3766.3013.45251.82
Operating Cycle
159.21701.37309.42205.90116.20288.54235.3478.3822.35104.8032.38288.54
Days of Payables Outstanding
1.17K748.13129.76151.48479.16632.90120.6648.5349.95N/AN/A632.90
Cash Conversion Cycle
-1.01K-46.75179.6654.42-362.95-344.35114.6829.84-27.60104.8080.11-362.95
Debt Ratios
Debt Ratio
N/AN/AN/A0.280.430.20N/AN/AN/A0.050.540.43
Debt Equity Ratio
N/AN/AN/A2.10-1.830.41N/AN/AN/A0.081.21-1.83
Long-term Debt to Capitalization
N/AN/AN/A0.672.190.08N/AN/AN/A0.02N/A0.08
Total Debt to Capitalization
N/AN/AN/A0.672.190.29N/AN/AN/A0.07N/A0.29
Interest Coverage Ratio
N/AN/AN/A-1.21KN/A-108.21N/AN/AN/AN/A-1.90K-108.21
Cash Flow to Debt Ratio
N/AN/AN/A-4.35-4.44-4.75N/AN/AN/A-18.54N/A-4.44
Company Equity Multiplier
1.231.501.187.46-4.231.981.291.722.751.422.21-4.23
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.77-2.36-1.57-1.77-1.27-5.76-1.48-0.49-0.46-3.99-0.39-1.27
Free Cash Flow / Operating Cash Flow Ratio
1.091.071.011.031.001.091.191.051.011.021.041.00
Cash Flow Coverage Ratio
N/AN/AN/A-4.35-4.44-4.75N/AN/AN/A-18.54N/A-4.44
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-6.09N/AN/AN/A-25.11N/A-6.09
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A-1.31%N/A-3.22%N/AN/A